• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COVIDIEN MFG SOLUTIONS S.A. ARGYLE; CATHETER, PERITONEAL, LONG-TERM INDWELLING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COVIDIEN MFG SOLUTIONS S.A. ARGYLE; CATHETER, PERITONEAL, LONG-TERM INDWELLING Back to Search Results
Model Number 8888412619
Device Problem Break (1069)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 07/23/2019
Event Type  malfunction  
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
According to the reporter, during use, there was dialysate leak that occurred at the catheter level.There was a breach observed at 1.5 centimeters from the outside of the catheter.It was mentioned no scissors or bandage have been used and that the implantation was more than 60 months old.They had to change the extension of the catheter and betacap and an injection intra-peritoneal of 2 grams of vancomycine in prophylaxis was given.There was no patient injury.
 
Event Description
According to the reporter, during use, there was dialysate leak that occurred at the catheter level.There was a breach (crack) observed at 1.5 centimeters from the outside of the catheter.It was mentioned no scissors or bandage have been used on the emergence of the catheter as the patient is allergic to all dressings and that the implantation was more than 60 months old.They had to change the extension of the catheter and betacap after a cut below the breach and an injection intra-peritoneal of 2 grams of vancomycine in prophylaxis was given.Chlorhexidine was used as a cleaning agent on the device.There were no unusual defect observed on the product prior to use and flushing was done without problem.There was no luer adapter issue.There was no blood loss but there was loss of peritoneal dialysate which was unquantifiable and blood transfusion was not required.There was no patient injury.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
According to the reporter, during use, there was dialysate leak that occurred at the catheter level.There was a breach (crack) observed at 1.5 centimeters from the outside of the catheter.It was mentioned that no scissors or bandage have been used on the emergence of the catheter as the patient is allergic to all dressings and that the implantation was more than 60 months old.They had to change the extension of the catheter and betacap after the cut below the breach and an injection intra-peritoneal of 2 grams of vancomycin in prophylaxis was given.Chlorhexidine was used as a cleaning agent on the device.There were no unusual defect observed on the product prior to use and flushing was done without problem.There was no luer adapter issue.There was no blood loss but there was loss of peritoneal dialysate which was unquantifiable and blood transfusion was not required.There was no patient injury.
 
Manufacturer Narrative
Additional information: a1, a2, a3, a4, b5, g4.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
Correction: (first name, last name, phone number, fax number).Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARGYLE
Type of Device
CATHETER, PERITONEAL, LONG-TERM INDWELLING
Manufacturer (Section D)
COVIDIEN MFG SOLUTIONS S.A.
edificio b20, calle #2
alajuela 20101
MDR Report Key9151837
MDR Text Key163310943
Report Number3009211636-2019-00220
Device Sequence Number1
Product Code FJS
UDI-Device Identifier10884521004450
UDI-Public10884521004450
Combination Product (y/n)N
PMA/PMN Number
K862046
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,user facility
Type of Report Initial,Followup,Followup,Followup
Report Date 04/09/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date02/01/2019
Device Model Number8888412619
Device Catalogue Number8888412619
Device Lot Number1404500007
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 09/11/2019
Initial Date FDA Received10/03/2019
Supplement Dates Manufacturer Received10/16/2019
11/11/2019
03/27/2020
Supplement Dates FDA Received10/30/2019
11/27/2019
04/09/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Age63 YR
Patient Weight86
-
-